Screener
Eastman Chemical EMN Impairment Charges
Impairment Charges at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Eastman Chemical in its filing.
Tagged under the XBRL concept us-gaap:AssetImpairmentCharges.
The source filing: Eastman Chemical’s 10-K, filed February 13, 2026.
- Filed
- Feb 13, 2026, 11:58 AM EST
- Fiscal year
- FY2025
- Accession
- 0000915389-26-000013
| (Dollars in millions) | For years ended December 31, 2025 | For years ended December 31, 2024 | For years ended December 31, 2023 |
|---|---|---|---|
| Adjustments to reconcile net earnings to net cash provided by operating activities: | |||
| Depreciation and amortization | 513 | 509 | 498 |
| Mark-to-market pension and other postretirement benefit plans (gain) loss, net | (6) | (54) | 53 |
| Asset impairment charges | 33 | 5 | — |
| Gain on sale of assets | — | — | (15) |
| Gain on divested businesses | — | — | (323) |
| Provision for (benefit from) deferred income taxes | 141 | (52) | (102) |
| Changes in operating assets and liabilities, net of effect of acquisitions and divestitures: |
ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
FAQ
- What is Eastman Chemical's impairment charges?
- Eastman Chemical (EMN) reported impairment charges of $33M in Q4 2025.
- What does impairment charges mean?
- Non-cash asset impairment charges added back in the operating cash flow reconciliation since they don't represent cash outflows.
Ask your AI about Eastman Chemical's impairment charges.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude